Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab.

Authors
Publication date
20 April 2023
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Ezid

    redirect
    Last time updated on 22/04/2023